• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry Product Image

Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

  • ID: 2424594
  • February 2013
  • Region: Global
  • 149 Pages
  • iCD Research

FEATURED COMPANIES

  • Abbot
  • BASF
  • DiscoveRx
  • Johnson and Johnson
  • Novartis
  • Semantelli
  • MORE

Global Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry is a new report that analyzes how pharmaceutical industry companies' procurement expenditures, business strategies, and practices are set to change in 2013-2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable).

This report gives access to category-level spending outlooks, budgets, supplier selection criteria, business challenges, and investment opportunities of leading purchase decision makers. The report also identifies the future growth of buyers and suppliers, MandA, capital expenditure, staff hiring, and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities, as well as access to information categorized by region, company type, and size.

Introduction and Landscape

Why was the report written?

This report is the result of an extensive survey drawn from an exclusive panel of leading global pharmaceutical industry executives; READ MORE >

FEATURED COMPANIES

  • Abbot
  • BASF
  • DiscoveRx
  • Johnson and Johnson
  • Novartis
  • Semantelli
  • MORE

Table of Contents
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Global pharmaceutical industry: profile of buyer respondents
1.4.2 Global pharmaceutical industry: profile of supplier respondents
2 Executive Summary
3 Global Pharmaceutical Industry Dynamics
3.1 Revenue Growth Projections in the Global Pharmaceutical Industry
3.1.1 Revenue growth projections by company type
3.1.2 Revenue growth projections by region
3.1.3 Revenue growth projections by company turnover
3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
3.2 Future Developments in Business Structure in the Global Pharmaceutical Industry
3.2.1 Future developments in business structure by buyers
3.2.2 Future developments in business structure by suppliers
3.2.3 Future developments in business structure by region
3.2.4 Future developments in business structure by company turnover
3.2.5 Future developments in business structure by senior level respondents
3.3 Change in Leading Company Strategies in the Global Pharmaceutical Industry
3.3.1 Change in leading company strategies by buyers
3.3.2 Change in leading company strategies by suppliers
3.3.3 Change in leading company strategies by region
3.3.4 Change in leading company strategies by company turnover
3.4 Merger and Acquisition (M&A) Activity Projections in the Global Pharmaceutical Industry
3.4.1 M&A activity projections by buyers
3.4.2 M&A activity projections by suppliers
3.4.3 M&A activity projections by region
3.4.4 M&A activity projections by company turnover
3.4.5 M&A activity projections by purchasing decision authority
3.4.6 Global pharmaceutical industry - expand abroad Vs M&A activity projections
3.5 Estimation of Capital Expenditure in the Global Pharmaceutical Industry
3.5.1 Estimation of capital expenditure by buyers
3.5.2 Estimation of capital expenditure by suppliers
3.5.3 Estimation of capital expenditure by region
3.5.4 Estimation of capital expenditure by company turnover
3.6 Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry
3.6.1 Planned change in staff recruitment activity by buyers
3.6.2 Planned change in staff recruitment activity by suppliers
3.6.3 Planned change in staff recruitment activity by region
3.6.4 Planned change in staff recruitment activity by company turnover
4 Global Pharmaceutical Industry Market Growth Outlook
4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
4.1.1 Demand in emerging markets by buyers
4.1.2 Demand in emerging markets by suppliers
4.1.3 Demand in emerging markets by region
4.1.4 Demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry - Growth Projections in Developed Countries
4.2.1 Growth projections in developed countries by buyers
4.2.2 Growth projections in developed countries by suppliers
4.2.3 Growth projections in developed countries by region
4.2.4 Growth projections in developed countries by company turnover
5 Threats and Opportunities for the Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2013–2014
5.1.1 Leading business concerns for 2013–2014 by company type
5.1.2 Leading business concerns for 2013–2014 by region
5.1.3 Leading business concerns for 2013–2014 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business
5.2.1 Actions to maintain and secure buyer business by buyers
5.2.2 Actions to maintain and secure buyer business by region
5.2.3 Actions to maintain and secure buyer business by company turnover
5.2.4 Actions to maintain and secure buyer business by purchasing decision authority
6 Global Pharmaceutical Industry Buyer Expenditure Activity
6.1 Annual Procurement Budgets in the Global Pharmaceutical Industry
6.1.1 Revenue growth vs. procurement budget
6.1.2 Annual procurement budgets by company type
6.1.3 Annual procurement budgets by region
6.1.4 Annual procurement budgets by company turnover
6.1.5 Annual procurement budgets by senior level respondents
6.2 Planned Change in Procurement Expenditure in the Global Pharmaceutical Industry
6.2.1 Planned change in procurement expenditure by buyer type
6.2.2 Planned change in procurement expenditure by region
6.2.3 Planned change in procurement expenditure by company turnover
6.2.4 Planned change in procurement expenditure vs. revenue growth optimism
6.2.5 Planned change in procurement expenditure vs. cost containment
6.3 Planned change in Procurement Expenditure by Product and Service Category
6.3.1 Planned change in procurement expenditure by product and service category - region
6.3.2 Planned change in procurement expenditure by product and service category - company turnover
6.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices
6.4.1 Variations in regional supplier prices by company type
6.4.2 Variations in regional supplier prices by region
6.4.3 Variations in regional supplier prices by company turnover
7 Global Pharmaceutical Industry: Procurement Behaviors and Strategies
7.1 Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection
7.2 E-procurement in the Global Pharmaceutical Industry
7.2.1 E-procurement in the global pharmaceutical industry by buyer type
7.2.2 E-procurement in the global pharmaceutical industry by region
7.2.3 E-procurement in the global pharmaceutical industry by company turnover
8 Appendix
8.1 Global Pharmaceutical Industry Survey Results– Closed Questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer

List of Tables
Table 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013
Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013
Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013
Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013
Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013
Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010–2013
Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010–2013
Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010–2013
Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013
Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry (%), 2013
Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
Table 21: M&A Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010–2013
Table 22: M&A Activity Projections - Global CROs and CMOs (%), 2010–2013
Table 23: M&A Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010–2013
Table 24: Global Pharmaceutical Industry M&A Activity Projections by Region (%), 2013
Table 25: Global Pharmaceutical Industry M&A Activity Projections by Turnover (%), 2013
Table 26: Global Pharmaceutical Industry M&A Activity Projections by Purchasing Decision Authority (%), 2013
Table 27: Global Pharmaceutical Industry - Expand Abroad vs. M&A Activity Projections(%), 2013
Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013
Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Turnover (%), 2013
Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010–2013
Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013–2014
Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013
Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing Decision Authority (%), 2013
Table 50: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010–2013
Table 51: Global Pharmaceutical Industry Buyers - Increase in Revenue Growth vs. Procurement Budget (%), 2013
Table 52: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
Table 53: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Region(%), 2013
Table 54: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
Table 55: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%), 2013
Table 56: Change in Procurement Expenditure – Global Pharmaceutical Industry Buyers (%), 2010–2013
Table 57: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
Table 58: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013
Table 59: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%), 2013
Table 60: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. Revenue Growth (%), 2013
Table 61: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. Cost Containment (%), 2013
Table 62: Future Change in Expenditure by Product and Service Category, Pharmaceutical Industry Manufacturers (%), 2013
Table 63: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013
Table 64: Increase in Expenditure by Product and Service Category - Buyers by Region , 2013
Table 65: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013
Table 66: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
Table 67: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%), 2013
Table 68: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Turnover (%), 2013
Table 69: Critical Success Factors for Supplier Selection – Global Pharmaceutical Industry Buyers, 2013
Table 70: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%), 2013
Table 71: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013
Table 72: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013
Table 73: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2013
Table 74: Survey Results - Closed Questions

List of Figures
Figure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010–2013
Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%), 2010–2013
Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013
Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry (%), 2013
Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%), 2013
Figure 13: M&A Activity Projections - Global Pharmaceutical Industry (%), 2013
Figure 14: M&A Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010–2013
Figure 15: M&A Activity Projections - Global CROs and CMOs (%), 2010–2013
Figure 16: M&A Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010–2013
Figure 17: Global Pharmaceutical Industry M&A Activity Projections by Region (%), 2013
Figure 18: Global Pharmaceutical Industry M&A Activity Projections by Turnover (%), 2013
Figure 19: Global Pharmaceutical Industry M&A Activity Projections by Purchasing Decision Authority (%), 2013
Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs M&A Activity Projections (%), 2013
Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013
Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013
Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013
Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013
Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013
Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013
Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Region (%), 2013
Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013
Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013
Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013–2014
Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013
Figure 48: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010–2013
Figure 49: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
Figure 50: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
Figure 51: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%), 2013
Figure 52: Change in Procurement Expenditure - Global Pharmaceutical Industry Buyers (%), 2010–2013
Figure 53: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
Figure 54: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013
Figure 55: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%), 2013
Figure 56: Future Change in Expenditure by Product and Service Category, Buyers , 2013
Figure 57: Future Change in Expenditure by Product and Service Category, Pharmaceutical Industry Manufacturers (%), 2013
Figure 58: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013
Figure 59: Increase in Expenditure by Product and Service Category - Buyers by Turnover (%), 2013
Figure 60: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013
Figure 61: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
Figure 62: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%), 2013
Figure 63: Critical Success Factors for Supplier Selection – Global Pharmaceutical Industry Buyers, 2013
Figure 64: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%), 2013
Figure 65: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013
Figure 66: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013
Figure 67: E–Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2013

- Eli Lilly
- Avid Radiopharmaceuticals
- Roche
- Johnson and Johnson
- Mozambica
- Mozambican Medicines Company
- Mylan Pharmaceuticals Private Limited
- AstraZeneca
- MedImmune
- WuXi AppTec
- Pfizer
- Bristol-Myers
- Sanofi
- Astellas Pharma
- Sanwa Kagaku Kenkyusho
- STS Health
- Avita Medical
- Guppy Plastics
- Mylan Laboratories
- TiGenix
- DiaMedica
- Suzhou Pharma
- Arrowhead Research
- Shire
- biOasis Technologies
- UCB
- Immunovative Therapies
- Lonza
- UBICHEM Group
- UBICHEM Pharma
- BASF
- Equateq
- SAFC
- Sigma-Aldrich
- Semantelli
- Novartis
- UMN Pharma
- Catalent Pharma Solutions
- Sihuan Pharmaceutical Holdings
- Dendreon Corporation
- DBV Technologies
- GENEWIZ
- Bayer HealthCare Pharmaceuticals
- Vitapath
- Nextrials
- LGC
- Quotient Bioresearch
- Bio-Rad Laboratories
- AbD Serotec
- MorphoSys AG
- NextWave Pharmaceuticals
- OPKO Health
- DiscoveRx
- BioSeek
- Poxel
- Nuron Biotech
- Takeda
- Takeda America Holdings
- LigoCyte Pharmaceuticals
- Block Engineering
- Lexmark International
- Acuo Technologies
- Zhejiang Hisun Pharmaceuticals
- Abbot
- Essex Woodlands
- Novavax
- CPL Biologicals
- Dr. Reddy's Laboratories
- Debiopharm Group
- Omkar Speciality Chemicals
- Thermo Fisher Scientific
- Bosch Packaging Technology
- Amgen
- TG Therapeutics
- Ildong Pharmaceutical
- Teva Pharmaceutical Industries
- Handok Pharmaceuticals
- GE Healthcare Life Sciences
- GE Healthcare
- Kiadis Pharma
- Aptuit
- Aegerion Pharmaceuticals
- Novasep
- ATS Labs
- Galapagos and Cangenix

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos